Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

Author： Parodi Guido   Luca Giuseppe   Moschi Guia   Bellandi Benedetta   Valenti Renato   Migliorini Angela   Carrabba Nazario   Antoniucci David  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.30, Iss.4, 2010-11, pp. : 446-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction

By Antoniucci D.   Rodriguez A.   Hempel A.   Valenti R.   Migliorini A.   Vigo F.   Parodi G.   Fernandez-Pereira C.   Moschi G.   Bartorelli A.   Santoro G.M.   Bolognese L.   Colombo A.  

Journal of the American College of Cardiology, Vol. 42, Iss. 11, 2003-12 ,pp. : 1879-1885

Elsevier

Access to resources Recommend Favorite

Safety and Efficacy of Tirofiban as an Adjunctive Therapy for Patients with St-Elevation Myocardial Infarction: A Comparison Versus Placebo and Abciximab

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 3, 2011-07 ,pp. : 147-153

Bentham Science Publishers

Access to resources Recommend Favorite

Bleeding Complications After Contemporary Pharmacoinvasive Therapy for ST Elevation Myocardial Infarction

By Gutierrez Matthew   Aggarwal Atul   Gilbert Kristin   Sobel Burton   Dauerman Harold  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 187-192

Springer Publishing Company

Access to resources Recommend Favorite

Association of Plasma Levels of Activated Protein C with Recanalization of the Infarct-Related Coronary Artery after Thrombolytic Therapy in Acute Myocardial Infarction - Role of plasminogen activator inhibitor

By Takazoe K.   Ogawa H.   Yasue H.   Sakamoto T.   Oshima S.   Arai H.   Moriyama Y.   Shimomura H.   Hirai N.   Kaikita K.   Soejima H.   Misumi K.   Hosoda K.  

Thrombosis Research, Vol. 95, Iss. 1, 1999-07 ,pp. : 37-47

Elsevier

Access to resources Recommend Favorite

Oral anticoagulation after myocardial infarction

By Arnesen H.  

Thrombosis Research, Vol. 109, Iss. 4, 2003-02 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite